Nps Pharmaceuticals Close to Being a Full-Fledged Pharmaceuticals Company

Summary


As expected, NPS Pharmaceuticals is now one step closer to becoming a full-fledged pharmaceuticals company.

The Salt Lake City-based company announced last week the positive results of its multi-year Phase III clinical trials on PREOS, a compound targeting osteoporosis in post-menopausal women.

See the full content of this document

Extract


Nps Pharmaceuticals Close to Being a Full-Fledged Pharmaceuticals Company

As part of its announcement, NPS announced it plans to file a new drug application by the end of 2004 with the Food & Drug Administration to obtain clearance to market PREOS.

For NPS (Nasdaq: NPSP) the announcement signals the ne...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company